Skip to main content
    V

    VivoSim Labs, Inc. (VIVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.12
    -0.00 (-2.68%)

    Market Cap: $2.58M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    VivoSim Labs, Inc. (VIVS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to VivoSim Labs are BioRestorative Therapies (BRTX), Revelation Biosciences (REVB) and Calidi Biotherapeutics (CLDI). By market cap, VivoSim Labs ranks 8th of the 13 companies on this page; Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest at $4.02M.

    Peer Comparison

    VIVS's revenue growth of -51.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    VivoSim Labs (VIVS)$2.58MN/A15.1x0.0%N/A-51.4%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Silexion Therapeutics Corp (SLXN)$1.29MN/A5.9x0.0%N/A0.0%0.00%
    Peer median$2.75MN/A5.9x0.0%-201.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to VivoSim Labs, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    Calidi Biotherapeutics Inc. (CLDI)
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Creative Medical Technology Holdings Inc (CELZ)
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors
    Bioatla Inc (BCAB)
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Silexion Therapeutics Corp (SLXN)
    Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine...
    SLXN competitors

    Frequently Asked Questions About VIVS

    Who are VivoSim Labs' main competitors?

    The companies most similar to VivoSim Labs include BioRestorative Therapies (BRTX), Revelation Biosciences (REVB), Calidi Biotherapeutics (CLDI), Liminatus Pharma, Inc. Class A Common Stock (LIMN) and PharmaCyte Biotech (PMCB), listed from the closest match.

    Who is VivoSim Labs' biggest competitor?

    Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest of the similar companies at $4.02M; BioRestorative Therapies (BRTX) is the closest match by business profile, size, sector and industry.

    How does VIVS stock compare with its competitors?

    VIVS' P/S is 15.1x against a peer median of 5.9x; its net margin is 0.0% against a peer median of 0.0%.

    Which of VivoSim Labs' competitors pays a higher dividend?

    VivoSim Labs pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is VivoSim Labs bigger than its competitors?

    No. VivoSim Labs is 8th by market cap among the 13 companies on this page; the largest is Liminatus Pharma, Inc. Class A Common Stock (LIMN) at $4.02M.